SECURITIES AND EXCHANGE COMMISSION
                       ----------------------------------
                             WASHINGTON, D.C. 20549

                                   FORM 10-QSB

            QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE

                         SECURITIES EXCHANGE ACT OF 1934

                FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2003

                            Commission File #2-89616

                      CONSOLIDATED MEDICAL MANAGEMENT, INC.
             (Exact name of registrant as specified in its charter)

                                     MONTANA

         (State or other jurisdiction of incorporation or organization)

                                   82-0369233
                      (IRS Employer Identification Number)

               11919 Sunray Avenue, Suite B, Baton Rouge, LA 70816
               (Address of principal executive offices)(Zip Code)

                                  225-292-5139
                (Registrant's telephone no., including area code)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Yes [X] No [ ]

The number of shares outstanding of the Company's common stock as of September
30, 2003 is shown below:

Title of Class Number of Shares Outstanding Common Stock, par value $.001 per
share 42,618,486.


1
<PAGE>
Documents Incorporated by Reference: None

                      CONSOLIDATED MEDICAL MANAGEMENT, INC.

                                   FORM 10-QSB

                                Table of Contents

PART I - FINANCIAL INFORMATION

Item 1 - Financial Information

Item 2 - Management's Discussion and Analysis of Financial Condition Operations

Item 3 - Controls and Procedures


PART II - OTHER INFORMATION

Item 2 - Changes in Securities and Use of Proceeds

Item 6 - Exhibits and Reports on Form 8-K

SIGNATURES


2
<PAGE>
                         PART I - FINANCIAL INFORMATION


ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS
The financial statements of the company are set forth beginning on page F-1.


                         PART I - FINANCIAL INFORMATION
                         ------------------------------


ITEM 1. FINANCIAL STATEMENTS

AS USED HEREIN, THE TERM "COMPANY" REFERS TO CONSOLIDATED MEDICAL MANAGEMENT
INC. UNLESS OTHERWISE INDICATED. CONSOLIDATED UNAUDITED INTERIM FINANCIAL
STATEMENTS INCLUDING A BALANCE SHEET FOR THE COMPANY AS OF THE QUARTER ENDED
SEPTEMBER 30, 2003, STATEMENT OF OPERATIONS, AND STATEMENT OF CASH FLOWS FOR THE
INTERIM PERIOD UP TO THE DATE OF SUCH BALANCE SHEET AND THE COMPARABLE PERIOD OF
THE PRECEDING YEAR ARE ATTACHED AS PAGES 3 THROUGH 5 AND ARE INCORPORATED HEREIN
BY THIS REFERENCE.


                 [THIS SPACE HAS BEEN LEFT BLANK INTENTIONALLY]




3
<PAGE>
<TABLE>
<CAPTION>
                                 CONSOLIDATED MINERALS MANAGEMENT, INC.
                                        (A MONTANA CORPORATION)
                                       CONSOLIDATED BALANCE SHEET
                                              (UNAUDITED)

                                                 ASSETS
                                                 ------


Current Assets                                                 September 30, 2003    December 31, 2002
--------------                                                --------------------  -------------------
<S>                                                           <C>                   <C>

Cash                                                          $            12,796   $           63,076
                                                              --------------------  -------------------

Total Current Assets                                                       12,796               63,076
                                                                                    -------------------

Other Assets
------------
Oil & Gas Properties                                          $            60,000               65,322
Investment in Intercontinental Fuels LLC                                1,650,000                    0
Note Receivable                                                         1,450,000                   00
                                                              --------------------  -------------------
     Total Other Assets                                                 3,160,000               65,322
                                                              --------------------  -------------------

          Total Assets                                        $         3,172,796   $          128,398
                                                              ====================  ===================


                      LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
                      ----------------------------------------------

Current Liabilities
-------------------


Notes Payable-Current Portion                                 $            19,170   $           25,767
Accounts Payable                                                          108,012              108,012
Accrued Expenses                                                          313,678              357,803
Convertible Debentures                                                    465,000              465,000
Debentures Payable                                                        350,000                    0
                                                              --------------------  -------------------

     Total Current Liabilities                                          1,255,860              956,582

Notes Payable - Long Term Portion                                         874,726               54,726
Convertible Debentures                                                  2,000,000                   **
                                                              --------------------  -------------------
     Total Long-Term Liabilities                                        2,874,726               54,726
                                                              --------------------  -------------------

     Total Liabilities                                        $         4,130,586   $        1,011,308
                                                              --------------------  -------------------

Commitments and Contingencies:
------------------------------

Stockholders' Equity
--------------------
     Preferred Stock
        20,000,000 authorized shares, par value $.001
        no shares issued and outstanding
     $0.001 par value, 50,000,000 shares authorized
     42,618,486 shares issued and outstanding as of
     September  30, 2003 and 28,679,436 shares issued
     and outstanding as of December 31, 2002.

     Common Stock                                             $            42,618
     Additional Paid-in-Capital                                         3,954,049            3,675,535
     Stock Subscription Receivable                                         (4,000)             (67,250)
     Retained Earnings (Deficit)                                       (4,950,457)          (4,519,878)
                                                              --------------------  -------------------

        Total Stockholders' Equity (Deficit)                             (957,790)            (882,910)
                                                              --------------------  -------------------

        Total Liabilities and Stockholders' Equity (Deficit)  $         3,172,796   $          128,398
                                                              ====================  ===================
</TABLE>


4
<PAGE>
<TABLE>
<CAPTION>
                            CONSOLIDATED MEDICAL MANAGEMENT, INC.
                                   (A MONTANA CORPORATION)
                            CONSOLIDATED STATEMENT OF OPERATIONS
                                         (UNAUDITED)

                            THREE MONTHS ENDED SEPTEMBER 30, 2003
                            -------------------------------------

                                   THREE MONTHS ENDED SEPT 30,  NINE MONTHS ENDED SEPT 30,
                                    ------------------------  ------------------------------
                                       2003         2002          2003            2002
                                    -----------  -----------  ------------  ----------------
<S>                                 <C>          <C>          <C>           <C>
Revenues                            $   60,000   $        0   $    75,042   $             0
--------

Operating Expenses
    Personnel Costs                    147,000            0       193,500            52,736
    Consulting                          10,700            0        18,650           154,000
    Legal and Professional              11,260       15,055        35,575            25,351
    Other Expenses                      31,460        2,258        84,879            13,667
                                    -----------  -----------  ------------  ----------------

    Total Operating Expenses        $  200,420   $   17,313   $   332,604   $       245,754

Income (Loss) from Operations         (140,420)     (17,313)     (257,562)         (245,754)

Other Income (Expenses)
      Interest Expense                       0      (13,046)      (11,625)          (37,717)
                                    -----------  -----------  ------------  ----------------

Income (Loss) before Income Taxes   $ (140,420)  $  (30,359)  $  (269,187)         (283,471)

Income Tax Expense                           0            0             0                 0
                                    -----------  -----------  ------------  ----------------

Net Income (Loss)                   $ (140,420)  $  (30,359)  $  (269,187)  $      (283,471)
                                    ===========  ===========  ============  ================

Net Income (Loss) per Share         $    (.003)  $  (.00138)  $    (.0063)  $        (.02).
                                    ===========  ===========  ============  ================
</TABLE>


5
<PAGE>
<TABLE>
<CAPTION>
                           CONSOLIDATED MEDICAL MANAGEMENT, INC
                                 (A MONTANA CORPORATION)
                              CONSOLIDATED STATEMENT OF CASH
                                       (UNAUDITED)
                             THREE MONTHS ENDED SEPTEMBER 30
                             -------------------------------


Cash Flows from Operating Activities:                             2003          2002
-------------------------------------                          -----------  -------------
<S>                                                            <C>          <C>
     Net Income (Loss)                                         $( 140,420)  $   (283,471)
     Adjustments to Reconcile Net Income (Loss) to
        Net Cash Provided by Operating Activities:
              Depreciation and Amortization
              (Increase) Decrease in Investment                  (750,000)
              (Increase) Decrease in Receivables                        0
              (Decrease) Increase in Accounts Payable              (6,685)         4,968
              (Increase) Decrease in Interest Payable                   0
              (Increase) Decrease in Accrued Expenses                   0         37,717
                                                               -----------  -------------

            Net Cash Provided (Used) by Operating Activities   $ (897,105)  $   (240,786)
                                                               -----------  -------------

Cash Flows from Investing Activities:
-------------------------------------

        Oil & Gas Properties                                       60,000        (31,107)
                                                               -----------  -------------

            Net Cash Provided (Used) by Investing Activities   $   60,000   $    (31,107)
                                                               -----------  -------------

Cash Flows from Financing Activities:
-------------------------------------
     Increase in Long-Term Debt                                   750,000
     Increase in Short-Term Debt                                        0          9,741
     Increase in Paid in capital                                   88,000        204,116
     Common Stock                                                   7,000         54,596
     Decrease in Stock Subscriptions Receivable                         0              0
                                                               -----------  -------------

            Net Cash Provided (Used) by Financing Activities   $  845,000   $    268,453
                                                               -----------  -------------

Net Increase (Decrease) in Cash                                     7,895         (3,440)

Cash, Beginning of period                                           4,901          5,470
                                                               -----------  -------------

Cash, End of period                                            $   12,796   $      2,030
                                                               ===========  =============

Supplemental Disclosure of Cash Flow Information
     Cash Paid During the Period for:                          $        0   $          0
                                                               ===========  =============
              Interest

              Income Taxes                                     $        0   $          0
                                                               ===========  =============
</TABLE>


6
<PAGE>
NOTE 1 - BASIS OF PRESENTATION
------------------------------

GENERAL
-------

The unaudited interim financial statements of the Company as of September 30,
2003 and for the three months and nine months ended September 30, 2003, included
herein have been prepared in accordance with the instructions for Form 10QSB
under the Securities Exchange Act of 1934, as amended, and Article 10 of
Regulation S-X under the Securities Act of 1933, as amended.  The December 31,
2002 Consolidated Balance Sheet was derived from audited financial statements,
but does not include all disclosures required by generally accepted accounting
principles.  Certain information and note disclosures normally included in
financial statements prepared in accordance with generally accepted accounting
principles have been condensed or omitted pursuant to such rules and regulations
relating to interim consolidated financial statements.

In the opinion of management, the accompanying consolidated unaudited interim
financial statements reflect all adjustments, consisting only of normal
recurring adjustments, necessary to present fairly the financial position of the
Company at September 30, 2003, and the results of their operations for the three
and nine months ended September 30, 2003 and September 30, 2002, and their cash
flows for the three and nine months ended September  30, 2003 and September 30,
2002.

The results of operations for such periods are not necessarily indicative of
results expected for the full year or for any future period.  These financial
statements should be read in conjunction with the audited consolidated financial
statements as of December 31, 2002 and related notes included in the Company's
Form 10-KSB filed with the Securities and Exchange Commission.

                                  ORGANIZATION

The Company was incorporated under the laws of the State of Montana on August
13, 1981.  The Company ceased its mining operations in 1985, and discontinued
all business operations in 1990.  In August of 2001, the Company decided to
refocus on the oil and gas industry and entered into several Letters of Intent
only one of which survived the due diligence process.


7
<PAGE>
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
---------------------------------------------------

ACCOUNTING METHOD
-----------------

Accounting policies of the Company conform to the generally accepted accounting
principles and reflect practices appropriate to the industry in which it
operates.  The significant policies are summarized below.

                                   RECEIVABLES

The Company, through an S-8 offering, grants options and stock to several
individuals for stock.  As of September 30, 2003 and December 31, 2002 there was
$4,000 and $67,250 owed to the Company for stock purchased through the S-8 stock
program.

                      PROPERTY, EQUIPMENT AND DEPRECIATION

Expenditures for property, plant and equipment are recorded at cost.  Renewals
and improvements, which extend the economic life of such assets, are
capitalized.  Expenditures for maintenance, repairs and other renewals are
charged to expense.  For major dispositions, the cost and accumulated
depreciation are removed from the accounts and any gain or loss in included in
the results of operations.

CASH FLOWS AND CONCENTRATION OF CREDIT RISK
-------------------------------------------

Cash consists principally of demand deposits at commercial banks.  These
balances, as reflected in the bank's records, are insured by the Federal Deposit
Insurance Corporation up to $100,000.  At December 31, 2002 and September 30,
2003, the Company's deposits did not exceed the insured limits.

EARNINGS PER COMMON SHARE
-------------------------

The Company adopted Financial Accounting Standards (SFAS) No. 128, "Earnings Per
Share," which simplifies the computation of earnings per share requiring the
restatement of all prior periods.

Basic earnings per share are computed on the basis of the weighted average
number of common shares outstanding during each year.

Diluted earnings per share are computed on the basis of the weighted average
number of common shares and dilutive securities outstanding.  Dilutive
securities having an anti-dilutive effect on diluted earnings per share are
excluded from the calculation.  The Company does not have any dilutive
securities as of September 30, 2003.


8
<PAGE>
NOTE 3 - INVESTMENT IN INTERCONTINENTAL FUELS,  LLC
---------------------------------------------------

On September 5, 2003 CMMI transferred its investment in the acquisition in the
assets of Palm Petroleum, Inc. to Intercontinental Fuels, LLC (IFL). CMMI had
accumulated costs totaling $2,750,000 in acquiring these assets.  In exchange
for a 75% membership interest in IFL, CMMI transferred certain assets totaling,
$1,650,000.  The remaining assets were transferred to IFL in exchange for a note
receivable of $1,100,000.

NOTE 4 - COVERTIBLE DEBENTURES AND NOTES PAYABLE
------------------------------------------------

The Company issued convertible debentures in 1998 that are subordinated to bank
debt and secured leases.  The debentures are otherwise unsecured but are given a
preference over unsecured debt.  The debentures include interest at fifteen
(15%) percent, interest is payable in monthly installments.  Each debenture has
a conversion right for each holder to convert the debenture principal to shares
of the Company's common stock at the greater of $2.50 per share or ninety (90%)
percent of the bid price, whichever is greater on the date of conversion.
Accrued interest and any principal amount not converted to shares of stock will
be paid in cash at conversion.  The debentures are due one year from date of
issue.  All debentures issued in 1998 were due in 1999, and they are in default
as of September 30, 2003.

The Company issued convertible promissory notes payable in 1998. The notes are
unsecured and include interest at ten (10%) percent, interest is payable in
monthly installments. Each note has a conversion right for each holder to
convert the note's unpaid principal to shares of the Company's common stock
based on $2.50 per share, or a total of 90,000 at the note holder's discretion.
Accrued interest and any principal amount not converted to shares of stock will
be paid in cash at conversion. As of December 31, the company had issued and
outstanding $325,00 in debentures. The notes were due July 31, 1999, and they
are in default as of June 30, 2003.

The Company has entered into an agreement with Spectrum Financial, Inc.
("Spectrum") whereby Spectrum will exchange shares it owns with the debenture
holder upon exercise of the debenture's conversion option, in satisfaction of
the Company's obligations under the conversion provisions.  In exchange,
Spectrum will then receive an unsecured note payable from the Company (see Note
7) for the face amount of the debenture surrendered.  During the year ended
December 31, 1998, Spectrum exchanged a total of 14,000 of its shares in
connection with this agreement and received five notes payable from the Company
totaling $35,000.

     Total Convertible Debentures and Notes Payable  $ 465,000
     Less: Current Portion                            (465,000)
                                                     ----------
     Long-Term Portion                               $       0
                                                     ==========


9
<PAGE>
The Company issued a $2,000,000 convertible debenture on April 15, 2003 which is
unsecured and includes interest at 5% per annum.  The debenture matures on April
15, 2006.  It is convertible at the option of the holder after April 15, 2004
into $2,000,000 of Common stock at a cost of 70% of the average bid price for
the stock for the immediate twenty days before the exercise.

The Company issued a $350,000 debenture on April 15, 2003 which is unsecured and
includes interest at 5% per annum.  The debenture matures on October 15, 2003.

The Company issued a $600,000 note payable on July 1, 2003 which is unsecured
and includes interest at 5% per annum.  The note is payable upon permanent
financing of Intercontinental Fuels, LLC (IFL) plant facility.  CMMI owns 75% of
the membership interest in IFL.

The Company issued a $150,000 note payable on July 5, 2003 which is unsecured
and includes interest at 4% per annum.  Interest is payable monthly and is due
January 6, 2004.

NOTE 5 - COMMON AND PREFERRED STOCK
-----------------------------------

COMMON STOCK
------------

The Company's common stock is $0.001 par value, there are 50,000,000 shares
authorized as of December 31, 2002 and September 30, 2003, the Company had
28,679,436 and 42,618,486 shares issued and outstanding, respectively.

PREFERRED STOCK
---------------

In 1998, the Company amended its articles to authorize Preferred Stock.  There
are 20,000,000 shares authorized with a par value of $0.001.  The shares are
non-voting and non-redeemable by the Company.  The Company further designated
two series of its Preferred Stock: "Series 'A' $12.50 Preferred Stock" with
2,159,193 shares of the total shares authorized and "Series 'A' $8.00 Preferred
Stock," with the number of authorized shares set at 1,079,957 shares.  As of
September 30, 2003 and December 31, 2002 there are no shares issued and
outstanding.


DIVIDENDS
---------

Dividends are non-cumulative, however, the holders of such series, in preference
to the holders of any common stock, shall be entitled to receive, as and when
declared payable by the Board of Directors from funds legally available for the
payment thereof, dividends in lawful money of the United States of America at
the rate per annum fixed and determined as herein authorized for the shares of
such series, but no more, payable quarterly on the last days of March, June,
September, and December in each year with respect to the quarterly period ending
on the day prior to each such respective dividend payment date.  In no event
shall the holders of either series receive dividends of more than one percent
(1%) in any fiscal year.  Each share of both series shall rank on parity with
each other share of preferred stock, irrespective of series, with respect to
dividends at the respective fixed or maximum rates for such series.


10
<PAGE>
CONVERSION PROVISIONS
---------------------

Any holder of either series may convert any or all of such shares into shares of
common stock of the Company at any time.  Said shares shall be convertible at a
rate equal to three (3) shares of common stock of the Company for each one (1)
share of Series "A" or $12.50 Preferred Stock.  The Series "A" $12.50 Preferred
Stock shall be convertible, in whole or in part, at any time after the common
stock of the Company shall maintain an average bid price per share of at least
$12.50 for ten (10) consecutive trading days.

Series "A" $8.00 Preferred Stock shall be convertible at a rate equal to three
(3) shares of common stock of the Company for each one (1) share of Series "A"
$8.00 Preferred Stock.  The Series "A" $8.00 Preferred Stock shall be
convertible, in whole or in part, at any time after the common stock of the
Company shall maintain an average bid price per share of at least $8.00 for ten
(10) consecutive trading days.

The preferential amount payable with respect to shares of either Series of
Preferred Stock in the event of voluntary or involuntary liquidation,
dissolution, or winding-up, shall be an amount equal to $5.00 per share, plus
the amount of any dividends declared and unpaid thereon.

Also see Note 4

NOTE 6 - COMMITMENT AND CONTINGENCIES

The company has not recognized any commitments or contingencies at this time.

The Company's financial statements are prepared using generally accepted
accounting principles applicable to a going concern, which contemplates the
realization of assets and liquidation of liabilities in the normal course of
business. However, the Company does not have significant cash or other material
assets, nor does it have an established source of revenues sufficient to cover
its operating costs that raises substantial doubt about its ability to continue
as a going concern.

ITEM 2. MANAGEMENT DISCUSSION AND ANAYLSIS OF FINACIAL CONDITION OR PLAN OF
OPERATIONS.

The following discussion should be read in conjunction with our unaudited
consolidated interim financial statements and related notes thereto included in
this quarterly report and in our audited consolidated financial statements and
Management's Discussion and Analysis of Financial Condition and Results of
Operations (MD&A") contained in our Form 10-KSB for the year ended December 31,
2002.  Certain statements in the following MD&A are forward looking statements.
Words such as "expects", "anticipates", "estimates" and similar expressions are
intended to identify forward-looking statements.  Such statements are subject to
risks and uncertainties that could cause actual results to differ materially
from those projected.


11
<PAGE>
GENERAL

Consolidated Medical Management, Inc. ("CMMI"), was incorporated under the laws
of the State of Montana on August 13, 1981 under the name Golden Maple Mining
and Leaching Company, Inc.  On May 23, 1998, we changed our name to Consolidated
Medical Management, Inc.  In August 2001, the Company decided to refocus on the
oil and gas industry and are currently doing business as Consolidated Minerals
Management, Inc.  CMMI's address was 7500 San Felipe, Suite 600, Houston, Texas
77063 until July 2003 when the Company moved offices to 11919 Sunray Avenue,
Suite B, Baton Rouge, LA 70816.


RESULTS OF OPERATIONS

CMMI secured funding that enabled the Company to drill two Nacatoch wells in
Caddo Parrish, Louisiana.  In December 2002, CMMI sold their interest in the
Nacatoch Light #1 and Bell #7 wells for $75,000.  CMMI has successfully raised
the capital to develop 10 additional Nacotoch wells in Caddo Parish, LA.  A
third well has been drilled and the Company is awaiting the results.

The Company acquired a 5% working interest in PAR Minerals Corporation's Snake
Bite Prospect (Richardson #1) in Edwards County, Texas.  CMMI has partnered with
PAR in an Ellenberger horizontal test.  The well began generating revenue sales
on March 16, 2003.  The interest in Snake Bite Prospect was sold in April, 2003.

CMMI acquired title in the assets of Palm Petroleum, Inc.  In the 3rd quarter
CMMI transferred its interest in this facility to Intercontinental Fuels, LLC on
September 5, 2003 in exchange for a 75% membership interest and a note
receivable of $1,100,000.

On September 15, 2003, CMMI acquired a 2.25% working interest in PAR Minerals
Corporation Snakebite Four Square Ranch #2, for $60,000.00.  This acquisition
gives CMMI the right, but not the obligation to participate in all of the wells
proposed for this project.


12
<PAGE>
COMPARISON OF QUARTER ENDED SEPTEMBER 30, 2003 TO THE QUARTER ENDED SEPTEMBER
30, 2002

For the quarter ended September 30, 2003, our net loss was $140,407 as compared
to $30,359 for the quarter ended September 30, 2002.  The increase is related to
an increase in consulting fees incurred from assistance developing a focused
business plan and strategy for obtaining the debt or equity financing that we
will need to acquire energy prospects.


LIQUIDITY AND CAPITAL RESOURCES

The Company used funds from private placements received from investors to invest
in two oil and gas wells to operate the company.  The Company sold their
interest in these two oil wells in April 2003.

The liabilities shown on the balance sheet are current trade payables, and
accrued expenses and convertible debenture expenses related to financing
activities when the Company was engaged in the delivery of turn-key management
services for the home health industry, predominately in south Louisiana.
Additionally, new liabilities represented by debenture and notes payable were
incurred in the acquisition of subsequent transfer of the Intercontinental
Fuels, LLC transaction.

The Company's recurring negative financial results raise substantial doubt about
the Company's ability to continue as a going concern.

The Company currently anticipates that its existing cash and cash equivalents
balance will fund operations and continue energy development at the current
level of activity into the fourth quarter of 2003.  The Company will need to
raise additional funds through additional debt or equity financing.  There can
be no assurance that additional equity or debt financing will be available when
needed or on terms acceptable to the Company.

The market price of the Company's common stock has fluctuated significantly
since it began to be publicly traded in 1998 and may continue to be highly
volatile. Factors such as the ability of the Company to achieve development
goals, ability of the Company to profitably complete energy projects, the
ability of the Company to raise additional funds, general market conditions and
other factors affecting the Company's business that are beyond the Company's
control may cause significant fluctuations in the market price of the Company's
common stock. The market prices of the stock of many energy companies have
fluctuated substantially, often unrelated to the operating or research and
development performance of the specific companies. Such market fluctuations
could adversely affect the market price for the Company's common stock.


13
<PAGE>
                                     PART II

Pursuant to the Instructions on Part II of the Form 10-QSB, Items 1, 3, and 5
are omitted.


ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

None


ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

EXHIBIT INDEX

EXHIBIT 31     Certifications
EXHIBIT 32.1   Certification of Principal Executive Officer and Principal
               Financial Officer pursuant to Section 302 of the Sarbanes Oxley
               Act of 2002, with respect to the registrant's quarterly report on
               Form 10qsb for the quarter ended September 30, 2003
EXHIBIT 32.2   Certification of Principal Executive Officer and Principal
               Financial Officer pursant to Section 906 of the Sarbanes Oxley
               Act of 2002, with repsect to the registrants quarterly report on
               Form 10QSB for the quarter ended September 30, 2003.


14
<PAGE>
                                   SIGNATURES

Pursuant to the requirements of section 13 or 15(d) of the Securities Exchange
Act of 1934, the undersigned has duly caused this Form 10-QSB to be signed on
its behalf by the undersigned, there unto duly authorized, in the City of Baton
Rouge, LA, on November 11, 2003.


CONSOLIDATED MEDICAL MANAGEMENT, INC.

By:  /s/ Timothy G. Byrd, Sr.

     Timothy G. Byrd, Sr.
     Chief Executive Officer, Acting Chief Accounting Officer, an


15
<PAGE>
                                  EXHIBIT INDEX
                                  -------------


EXHIBIT 31     Certifications

EXHIBIT 32.1   Certification of Principal Executive Officer and Principal
               Financial Officer pursuant to Section 302 of the Sarbanes Oxley
               Act of 2002, with respect to the registrant's quarterly report on
               Form 10qsb for the quarter ended September 30, 2003

EXHIBIT 32.2   Certification of Principal Executive Officer and Principal
               Financial Officer pursant to Section 906 of the Sarbanes Oxley
               Act of 2002, with repsect to the registrants quarterly report on
               Form 10QSB for the quarter ended September 30, 2003.


<PAGE>